US Stock MarketDetailed Quotes

EVH Evolent Health

Watchlist
  • 10.020
  • +0.050+0.50%
Close Feb 14 16:00 ET
  • 10.050
  • +0.030+0.30%
Post 20:01 ET
1.17BMarket Cap-10.89P/E (TTM)

Evolent Health Key Stats

Evolent Health Q4 2024 Estimates Date

Currency:USDFeb 20, 2025

Estimate YoY
Revenue
650.92M
+17.06%
EPS
-0.28
+21.23%
Strong Buy

Feb 11, 2025

Evolent Health Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 592.097M--
Feb 20, 20252024/Q4-- / 650.916M--
Nov 7, 20242024/Q3621.401M / 627.151M--
Aug 8, 20242024/Q2647.145M / 636.414M--
May 9, 20242024/Q1639.653M / 598.902M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 592.097M--
Feb 20, 20252024/Q4-- / 650.916M--
Nov 7, 20242024/Q3621.401M / 627.151M--
Aug 8, 20242024/Q2647.145M / 636.414M--
May 9, 20242024/Q1639.653M / 598.902M--

Unlock Free Earnings Estimates

Evolent Health Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 11, 2025

Strong Buy

  • Buy

    92.31%
  • Hold

    7.69%
  • Sell

    0.00%

Price Target

No Data